Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Channelview ISD Selects Care Solace for Mental Healthcare Services


Students can’t learn if they aren’t supported mentally, physically and academically, and staff can’t help if they don’t have access to the right resources. Partnering with Care Solace will help us bridge this gap and offer quality, trusted mental healthcare resources to our community.

Channelview Independent School District (ISD) has selected Care Solace, an organization determined to calm the chaos of mental healthcare coordination, to extend access to mental health care and resources for families and staff. Care Solace equips school districts with a web-based tool that makes it easier to connect with both community-based and virtual mental healthcare providers and programs.

“We are incredibly excited to partner with Care Solace, and know this partnership will benefit our community in a very unique way,” said Greg Ollis, Superintendent at Channelview ISD. “Mental health is not something that should be taken lightly, and we are now able to offer our staff, teachers, parents, and students an outlet for them to seek the help they need.”

Located in an unincorporated area outside of Houston, Texas, 80 percent of Channelview ISD students are economically disadvantaged (TAPR, 2019). Limited community-based care resources and an increased demand for student and staff mental healthcare led the school district to seek additional support through Care Solace.

With Care Solace, families and staff gain access to a dedicated Care Concierge team, with experts available around-the-clock to guide users through processes related to insurance, provider availability, wait times and scheduling. Care Solace’s care navigation system uses proprietary technology and a vast database of behavioral and mental healthcare resources to find carefully vetted therapists and programs in minutes.

“Students can’t learn if they aren’t supported mentally, physically and academically, and staff can’t help if they don’t have access to the right resources,” said Karen Bryant, Ed.D, Director of Testing, Counseling, 504, RTI, and Dyslexia at Channelview ISD. “Partnering with Care Solace will help us bridge this gap and offer quality, trusted mental healthcare resources to our community.”

More than 90,000 school staff and parents at partnering school communities of Care Solace used the pre-screening tool, with at least 40,000 students receiving mental healthcare support as a result. Care Solace has facilitated an estimated 4,500 crisis interventions.

“Creating a healthy environment for learning in the 2020-21 school year has arguably never been more challenging for staff and families,” said Chad Castruita, founder of Care Solace. “We are proud to support Channelview ISD in prioritizing the wellbeing of its school community by providing timely access into mental healthcare services.”

Care Solace is now available to Channelview ISD families and staff. For more information about Care Solace, please visit https://home.caresolace.com/.

About Channelview ISD

The Channelview Independent School District is a rapidly growing school district with 9,500 students. The mission of CISD is to provide an educational program which will develop and enhance our students’ intellectual, social, emotional and physical growth in order to encourage them to become creative, responsible, patriotic contributing members of society. Inherent within this mission is the belief that all students can learn, and that school can make a difference in the lives of its students. Channelview ISD is a 6A school district located in an unincorporated area situated on the Houston Ship Channel approximately 15 miles east of downtown Houston. The district has twelve campuses, an administration building, fairgrounds, maintenance headquarters and a transportation facility. There is a Pre-K center, seven elementary schools, two junior high schools, one ninth grade center, one high school, an alternative high school.

About Care Solace

Care Solace is on a mission to calm the chaos associated with mental healthcare coordination for high school and college students. The organization’s web-based system works alongside multi-tiered systems of support (MTSS) as a tool for school staff and families to connect with community-based mental healthcare resources and providers. The proprietary care navigation system taps into a vast database of mental healthcare resources to find carefully vetted local therapists and programs in minutes. In 2019, more than 80,000 school staff and parents used the Care Solace pre-screening tool. At least 30,000 students received mental healthcare support as a result. To learn more, visit http://www.caresolace.com.

Share article on social media or email:

Aluminum, Upcoming Webinar Organized by Constantia Flexibles and Xtalks


Xtalks Logo

Xtalks Life Science Webinars

This webinar will show participants how to take advantage of aluminum for a multitude of food and consumer product packaging options, while maintaining the integrity of your products and ensuring more eco-friendly packaging that meets modern consumer’s demand for sustainability.

Consumers today care as much about food packaging as the product inside. They are demanding recyclable, sustainable materials to contain their favorite foods and personal care articles and are even willing to pay a premium for these products.

As food and consumer goods manufacturers are looking to reduce their reliance on plastics and lower their carbon footprint, the world of eco-friendly packaging materials can be overwhelming and confusing. First and foremost, alternative packaging materials must accomplish the necessary tasks of preserving food freshness, extending shelf life and being compatible with manufacturing processes.

Enter aluminum, a material that has been safely used for food packaging applications for over a century. Find out more about this versatile, but stable material and understand what are the properties that make it an ideal and sustainable packaging solution.

This webinar will show participants how to take advantage of aluminum for a multitude of food and consumer product packaging options, while maintaining the integrity of your products and ensuring more eco-friendly packaging that meets modern consumer’s demand for sustainability.

Join Dr. Thomas Greigeritsch, VP Group Sustainability, Constantia Flexibles, Dr. Martin Kornfeld, VP R&D Competence Center Aluminum and Foil Laminates, Constantia Flexibles and Thomas Schulz, VP Brand Management Group, Constantia Flexibles, in a live webinar on Monday, October 5, 2020 at 8am EDT (1pm BST/UK).

For more information or to register for this event, visit The Next Level of Sustainable Food Packaging: Aluminum.

ABOUT CONSTANTIA FLEXIBLES

Constantia Flexibles is one of the world’s leading manufacturers of flexible packaging with 100 years’ experience in the industry. The group supplies its products to numerous multinational corporations and local market leaders in the food, pet food, confectionery, home care, personal care and pharmaceutical industries, being active in the world’s most attractive and fastest-growing markets for flexible packaging.

The group is a global player with a strong European regional focus and presence in Europe, Russia, USA, Mexico and India, and it is recognized for premium positioning, leading technology, customer proximity and highly efficient production facilities.

To learn more about Constantia Flexibles visit: https://www.cflex.com/

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

DiabetesSisters Welcomes Leaders To 6th Annual Institute


“Despite a global pandemic, DiabetesSisters continues to focus on the social, emotional, and educational needs of women living with diabetes,” said Anna Norton, CEO. “We have continued to serve our community virtually. “

DiabetesSisters is excited to welcome 40 PODS (Part of DiabetesSisters) Leaders to its sixth annual Leadership Institute on October 3 and 4, 2020. Institute participants from more than 30 locations across the US will engage with expert speakers, DiabetesSisters staff, and each other to create open, welcoming atmospheres that encourage honest discussions; learn more about diabetes-related topics such as gastroparesis and mental health; and share stories of their own leadership challenges and successes. This year, DiabetesSisters will conduct the Institute virtually, maintaining safe physical distance.

Invited speakers at the DiabetesSisters Leadership Institute include:

  • Sarah Schuster, TheMighty.com
  • Sarah Koenck, living with diabetes and gastroparesis, nutrition and health coach
  • Stacey Divone, living with diabetes and gastroparesis, diabetes advocate
  • Melissa Lee, Tidepool
  • Ginger Viera, author and health coach
  • Gayle McKenna, PODS Leader, DiabetesSisters of Ventura County/San Fernando Valley, CA
  • Jennifer Stanton, PODS Leader, DiabetesSisters of Jacksonville, FL
  • Anne Dalin and Denise Scheffler, PODS Leaders, DiabetesSisters of Bridgewater, NJ
  • Shailja Mathur, PODS Leader, DiabetesSisters of Old Bridge, NJ
  • Janet Doolin, PODS Leader, DiabetesSisters of Pittsboro, NC
  • Sara Pollack, PODS Leader, DiabetesSisters of South Riding/Chantilly, VA

Volunteer PODS Leaders represent DiabetesSisters in their communities by facilitating inclusive support and education groups of their peers: other women living with or at risk of any type of diabetes or prediabetes. All meetings are currently held via remote platform or conference call due to COVID-19 pandemic regulations and guidelines.

“Despite a global pandemic, DiabetesSisters continues to focus on the social, emotional, and educational needs of women living with diabetes,” said Anna Norton, CEO. “We have continued to serve our community virtually during this time with online programs, and the Leadership Institute is among those services. We are excited to utilize online resources to reach more PODS Leaders than we have in past years.”

A DiabetesSisters signature program, PODS Meetups began in Raleigh, NC in 2010 and has grown to support nearly 40 monthly meetups in various locations throughout the US. The program provides encouragement, education, and peer support to women living with diabetes and prediabetes and serves more than 2,300 women annually.

DiabetesSisters recognizes and appreciates 2020 Leadership Institute sponsors: The Allergan Foundation, Boehringer Ingelheim-Lilly Alliance, and Novo Nordisk, and remote platform sponsor Jazz Pharmaceuticals.

About DiabetesSisters

A 501(c)(3) nonprofit, DiabetesSisters is the only organization nationwide focusing exclusively on women living with diabetes. Our mission is to improve the health and quality of life of women living with and at risk of diabetes and to advocate on their behalf. DiabetesSisters has a 50,000+ member peer network that unites women with diabetes for the purpose of support, education and advocacy. Signature programs include monthly peer support meetings (PODS Meetups); the Minority Initiative Program; Annual Leadership Institute for volunteer leaders; online expert articles, blog posts, and forums; and conferences throughout the US. For more information, visit diabetessisters.org.

Share article on social media or email:

Institute For Human Optimization Appoints Dr. John F. Koloski to Medical Advisory Board


Institute for Human Optimization, John F. Koloski, DC,  Anil Bajnath, MD, MBA, IFMCP, ABAARM, Spinal Optimization

Dr. Bajnath and Dr. Koloski

We are not only thrilled to have Dr. Koloski share his passion with the Institute, but we are also excited to have his hands and technology available to keep our own spines’ optimized.

The Institute For Human Optimization (IFHO), a precision medical research group and integrated private practice headquartered in Annapolis, MD, today announced the appointment of chiropractor, John F. Koloski, DC, to their Medical Advisory Board.

“John has far exceeded the standard of care in his private practice. He is a master of his craft and combines it with advanced healing technologies leading to some impressive outcomes, even in patients who previously been told their only options were invasive surgery or a lifetime of medication,” said Dr. Anil Bajnath, MD, Chief Executive Officer and Founder of IFHO.

“We are not only thrilled to have Dr. Koloski share his passion with the Institute, but we are also excited to have his hands and technology available to keep our own spines’ optimized.”

Dr. Koloski will oversee IFHO’s development and innovation of non-surgical spine care and spinal optimization protocols. He will lead research and development to create reproducible non-invasive outcomes, reduce systemic utilization of pain medications, and avoid unneeded spinal surgeries. Ultimately, raising the standard of spine care.

“I’ve always been passionate in practice about healing spines naturally — it’s an honor to be joining this incredible team of forward-thinking medical professionals and practitioners. As doctors, our focus is to optimize health and longevity, not just identify and treat disease,” remarked Dr. Koloski.

About IFHO:

The Institute For Human Optimization, founded by Anil Bajnath, MD, MBA, IFMCP, ABAARM, and author of The Longevity Equation, provides the most comprehensive Scientifically Data-Driven Personalized Wellness. No matter where you’re at in life, it’s never too late to begin investing in your Biological401K™ of health to improve vitality. For more information, visit: http://www.ifho.org.

About Dr. John F. Koloski:

Dr. John F. Koloski is the founder of the Spinal Optimization System™ (‘SOS’), the answer to the spine’s distress signals. The SOS™ is the premier solution for addressing spine pain and provides an alternative to spinal surgery in many cases. His private practice services Anne Arundel County, embedded in the Annapolis, Arnold, and Severna Park communities. For more information or to schedule a consult, visit: http://www.drkoloski.com.

Share article on social media or email:

Regency Announces Support for Human-Animal Bond Research Institute


News Image

Supporting pet owners and veterinarians at these difficult times is so important, which is why HABRI is proud to partner with Regency on research and education around this critical aspect of the human-animal bond,” said Steven Feldman, Executive Director of HABRI.

The Human-Animal Bond Research Institute (HABRI) announced today that Regency, a leading national provider of pet aftercare services, has become an official supporter of HABRI and its research on the health benefits of companion animals.

“Regency’s mission of compassion and respect for the human-animal bond aligns very strongly with HABRI and its mission,” said Scott Buttz, Chief Operating Officer at Regency. “Animals bring unconditional love into this world, and part of honoring their lives includes investing in the human-animal bond at every stage.”

“When pet owners lose their beloved family members, their pets, Regency helps to make the process easier for all involved,” said Steven Feldman, Executive Director of HABRI. “Supporting pet owners and veterinarians at these difficult times is so important, which is why HABRI is proud to partner with Regency on research and education around this critical aspect of the human-animal bond.”

Regency works directly with pet owners and partners with veterinarians to provide nationally recognized, individualized aftercare services to clients, recognizing the loss of a pet can be one of the most difficult experiences for families. The Regency Family is recognized as “partners of choice” in their local communities for adhering to a stringent code of ethics and industry standards.

Scientific evidence increasingly shows that pets improve humans’ heart health; alleviate depression; increase well-being; support child health and educational development; and contribute to healthy aging. The benefits of the human-animal bond impact more than just human health. Findings from a HABRI survey of 2,000 pet owners demonstrate that knowledge of the scientific research supporting the health benefits of the human-animal bond motivates pet owners to take better care of their pets. Knowledge of the health benefits of pets also helps encourage pet ownership, as 81 percent of pet owners surveyed stated that they are more like to get another pet in the future if the one they have now passes away.

“A positive end of life and aftercare experience can have a significant impact on the decision to get another pet in the future, and can also help veterinarians and their staff navigate this difficult aspect of their profession,” added Feldman.

About Regency

Regency is the leading pet aftercare services provider in the United States. Serving pet families and partnering with veterinarians across the country, the Company provides continuity of compassionate care through unparalleled service, transparency, and technology. Regency has expanded rapidly into new markets, advanced total service delivery through certified industry leading operators and continues to innovate in order to provide the best services, value and care to families at their time of need. For more information about Regency, please visit http://www.regencyfamily.com.

About HABRI

The Human Animal Bond Research Institute (HABRI) is a not-for-profit organization that maintains the world’s largest online library of human-animal bond research and information; funds innovative research projects to scientifically document the health benefits of companion animals; and informs the public about human-animal bond research and the beneficial role of companion animals in society. For more information about the HABRI Foundation, please visit http://www.habri.org.

Share article on social media or email:

CURIS System Chosen as Semi-Finalist for new COVID-19 Response Challenge from New York MTA and The Transit Innovation Partnership


The portable CURIS Decontamination System for SARS-CoV-2 (COVID-19)

We are confident that our state-of-the-art disinfection technology system would help make the NY MTA transit system one of the safest in the world

CURIS System is proud to announce today that is has been selected as a semi-finalist in The Transit Innovation Partnership and the New York Metropolitan Transportation Authority’s (MTA) new COVID-19 Response Challenge to engage the private tech industry and to rapidly evaluate and deploy innovative technologies that make transit safer, healthier and more responsive to customer and workforce needs in light of the global pandemic.

As part of the proposal for submission, CURIS was required to state how its technology makes transit safer, healthier and more responsive amid the COVID-19 pandemic and how the product addresses the problem in the context of public transit in the New York metro region. CURIS System drew from its already-tested and proven experience with other major metropolitan transit companies, including the City of Portland’s mass transit provider TriMet and others, to demonstrate how its CURoxide™ Hydrogen Peroxide blend and fogging system protects passengers against COVID-19 and other infectious disease. CURoxide is the only pulse fogging system included on the EPA’s List-N for efficacy against SARS-CoV-2 (COVID-19) and has shown to be 99.9999% effective in killing the most resistant pathogens, while equally as important proving safe to administer and leaving behind no toxic or damaging residues.

With just a single human operator, the CURIS Decontamination System is the first portable, hydrogen peroxide-based fogging system capable of disinfecting a room or enclosed area via patented pulse technology. It has revolutionized disinfection practices and cleaning protocols, changing expectations of germ safety from “attempts to just clean better” to an achievable, measurable kill result of dangerous germs. While most systems rely on dispensing chemicals and turning off once the desired time is achieved or depend on manual spraying, CURIS goes a step further by focusing on a ‘maintained pathogen-kill zone.’ Its system is designed to reduce human error with a hands-free system for remote operation that allows the operator to monitor, manage, measure, track and report, including the ability to quickly prove, and continuously improve, decontamination efforts.

Unlike other systems, CURoxide provides 100% touchless comprehensive disinfection to achieve a 99.9999% kill rate without exposing staff or transit passengers to harmful chemicals or pathogens. In addition, the use of the remote CURIS® hydrogen peroxide pulse fogging with onboard smart technology enables staff to treat rail cars or buses from outside the space without ever coming into contact with dangerous germs or harmful chemicals. Vehicles can be disinfected in between routes or at the end of the day, which is key to protecting everyone involved. As an added bonus, CURIS’ cloud-based data management and mobile app facilitate remote operation, report generation and detailed analysis.

“As we all sadly saw, the pandemic hit New York as hard as anywhere in the world, so we are very pleased to have been selected as a semi-finalist of this COVID-19 Response Challenge from New York’s MTA and The Transit Innovation Partnership,” said Frances Grinstead, CEO of CURIS System. “We are confident that our state-of-the-art disinfection technology system not only would help make their transit system one of the safest in the world, but it could be done so in a way that’s easily manageable and reportable with proven results after each process and in no way harmful to operators, passengers or employees.”

The CURIS Decontamination System was designed and is manufactured in the U.S.A. and has been in use for more than seven years to stop the spread of infectious disease in commercial settings across the world, including by the National Guard, which was deployed to fight against COVID-19 and many more. It is made to effectively work in such environments as:


  • Transportation systems, including buses, airplanes, subways, taxis
  • Emergency Response Operations, including fire stations, police stations
  • Schools
  • Medical facilities, including hospitals, assisted living/long-term care facilities
  • Laboratory spaces
  • Sports facilities and gyms
  • Military facilities

About CURIS® System

Headquartered in Oviedo, Florida, CURIS System provides the most efficacious germ-killing disinfectant solution with no harmful residues available on the market today. Established in 2014, CURIS’ innovative and patented hydrogen peroxide fogging system has revolutionized portable, high-level disinfection, making hospital-grade decontamination accessible across multiple markets. Its EPA-registered “No Touch” disinfection system uses pulse hydrogen peroxide fog to kill germs and odors. The system is easy to use, portable (roll-behind or hand carry), eco-friendly, non-corrosive and leaves behind NO harmful residues. The CURIS app can be used for remote activation and cloud-based data storage for optimal tracking, management and reporting. For more information, please visit http://www.curissystem.com

Share article on social media or email:

ArcheMedX “COVID-19’s Impact on Virtual Tech in Clinical Trials” Reveals New Priorities for Sponsors, CROs in a New Remote World


89% of trial leaders are rapidly adopting remote and virtual technologies, particularly across study start-up.

Today, ArcheMedX, a leader in behavior-based learning and operational insights for life sciences and healthcare organizations, announced the results of its new survey, “COVID-19’s Impact on Virtual Tech in Clinical Trials.” The findings reveal brand-new insights into how clinical trial leaders in pharmaceuticals, biotech, and clinical research organizations are accelerating the use of virtual solutions to advance clinical research in the current and post-pandemic environment.

The report found that 89% of trial leaders are rapidly adopting remote and virtual technologies, particularly across study start-up, and cutting through the inertia that often hinders such changes. These insights are especially relevant, as clinical operations teams increase the pace of resuming studies in an effort to pursue clinical research despite the continued impact of the pandemic.

More specifically, sponsors and CROs showed that clinical trial start-up activities were the most “digitally immature” and thus most ripe for virtualization. Across site selection, investigator meetings, and site initiation, respondents overwhelmingly agreed that they will be increasing the use of virtual methods, or replacing face-to-face interactions altogether.

The ArcheMedX report revealed that sponsors and CROs are also more concerned about how they select and prepare study sites to conduct their trials. Despite a majority of sponsors and CROs believing their approach to preparing sites was effective pre-COVID, 80% now believe they need to improve which sites fully understand inclusion/exclusion criteria for a trial and 73% report they need to improve their ability to identify which sites understand IP and sample management. Overall, 78% of respondents now say they have major improvements to make in identifying trial-ready sites.

“The results of the survey confirmed what we’ve heard anecdotally for years: that clinical operations leaders — both sponsors and CROs — recognize that they’re losing valuable time to preventable errors and delays due to ineffective study startup processes,” said Joel Selzer, CEO of ArcheMedX. “COVID-19 has forced sponsors and CROs to embrace a new, virtualized approach to selecting, preparing, and initiating their teams and sites which can dramatically improve overall study performance.”

For example, COVID-19’s restrictions have catalyzed the industry into a major change in perception around the utility of virtual meetings. 61% of sponsors said they are converting all clinical operations meetings to virtual ones, including Principal Investigator (PI) meetings and site initiation visits.

Most striking, 74% of respondents now believe that virtual PI meetings can be just as or more effective than those conducted in person vs. the 68% who had said PI meetings should only be held in person before the pandemic. The report also found site initiation visits ripe for virtual disruption – with 74% of sponsors committing to increased virtual delivery during site initiation and 90% of CROs seeking to fully virtualize site personnel training.

“COVID-19 has forced us to see the benefit of having virtual/electronic systems in place to mitigate unforeseen occurrences along the lifespan of a clinical study. Electronic tools are obviously not new, but embracing the tools is uncomfortable,” said Kevin Crawford, Director of Clinical Operations at Tenax Therapeutics, Inc. “I find it interesting, but not surprising, that the ArcheMedX report shows CROs to be more bullish on the technology, especially around investigator meetings and training. Without having a modality to distribute their knowledge to a CRO in a systematic, verified, trusted way, there is a reasonable concern that the study is “being thrown over the fence.” It may be unnecessary angst, but based on ArcheMedX data, it certainly exists.”

ArcheMedX provides a software platform, Ready, that enables CROs and Sponsors to predict and improve clinical trial site and team performance. The findings in the report mirror the increased adoption Ready has experienced across the industry as the platform reveals precisely which sites, teams, and individuals are likely to be high performers and enables CROs and Sponsors to remediate potential risk areas — earlier than ever before.

According to Kelly Ritch, EVP of Clinical Research Solutions at ArcheMedX. “Sponsors have made it clear that they’re expecting to adopt virtual technology throughout the study start-up – which has been primarily conducted in-person until now. This also aligns perfectly with their increased need to better measure trial site readiness, as the wider adoption of virtual technology makes more accurate site and team assessment a reality.”

To learn more about Ready by ArcheMedX, visit http://www.archemedx.com/ready.

About ArcheMedX: ArcheMedX enables companies across the life sciences and healthcare industries to accelerate the development and adoption of new clinical therapies and best practices. We do this through a data-powered approach to upskilling and evaluation.

ArcheMedX’s flagship product, Ready, predicts and improves how teams and clinicians will apply knowledge and skills in real-world scenarios by applying behavioral science to enhance how individuals learn and retain information. Ready is used by global CROs, sponsors, and healthcare organizations to inform operational decisions and improve performance for over 100,000 clinicians and clinical research professionals worldwide.

Press kit:

Summary: https://www.archemedx.com/corp-blog/virtual-clinical-trials-survey-reveals-study-start-up/

Full report: https://www.info.archemedx.com/covid-impact-clinical-operations-report

Share article on social media or email:

Team cbdMD Athlete Jessica-Rose Clark Wins Bantamweight Division in UFC Fight Night 178


cbdMD is proud to celebrate a night of triumph for Team cbdMD athlete and mixed martial arts expert, Jessica-Rose Clark, who won the women’s bantamweight division match during UFC Fight Night 178.

cbdMD is proud to celebrate a night of triumph for Team cbdMD athlete and mixed martial arts expert, Jessica-Rose Clark, who won the women’s bantamweight division match during UFC Fight Night 178.

“The world really saw how complete of a fighter Jessy is with this fight, neutralizing takedowns and showing full standup domination. The bantamweight division is clearly where she belongs.”

cbdMD, Inc. (NYSE American: YCBD, YCBD PR A) (the “Company”), one of the leading, and most highly trusted and recognized cannabidiol (CBD) brands, is proud to celebrate a night of triumph for Team cbdMD athlete and mixed martial arts expert, Jessica-Rose Clark, who won the women’s bantamweight division match during UFC Fight Night 178. Airing this past Saturday night before a national audience from UFC Apex in Las Vegas, Clark took to the Octagon in dominant fashion – earning a resounding victory against Sarah Alpar during the Prelims Card. Clark overwhelmed Alpar and claimed the win via TKO stoppage during round three.

Though Clark was favored by oddsmakers, she certainly didn’t look past her opponent. “This sport is the love of my life. So, you’re going to see me fighting for my life out there,” Clark said.

“The world really saw how complete of a fighter Jessy is with this fight, neutralizing takedowns and showing full standup domination. The bantamweight division is clearly where she belongs. She came into the fight mentally and physically in optimum shape, and we are honored to have her utilize and represent the cbdMD brand,” said Hans Molenkamp, Vice President of Sports Marketing at cbdMD.

As for what’s next for Clark, things are certainly moving quickly in her division. Odds are she will fight early next year, before proceeding to fight for the Bantamweight belt thereafter.

About cbdMD, Inc.

cbdMD, Inc. is one of the leading and most highly trusted and recognized cannabidiol (CBD) brands whose current products include CBD tinctures, CBD capsules, CBD gummies, CBD topicals, CBD bath bombs and CBD pet products. cbdMD is also a proud partner of Bellator MMA and Life Time, Inc., and has one of the largest rosters of professional sports athletes who are part of “Team cbdMD.” To learn more about cbdMD and our comprehensive line of over 100 SKUs of U.S. produced, Non THC1 CBD products, please visit http://www.cbdMD.com, follow cbdMD on Instagram and Facebook, or visit one of the 6,000 retail outlets that carry cbdMD products.

Forward-Looking Statements

This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as ”should,” ”may,” ”intends,” ”anticipates,” ”believes,” ”estimates,” ”projects,” ”forecasts,” ”expects,” ”plans,” and ”proposes.” These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including, without limitation, statements made with respect to the expansion of the consumer market for CBD products and our ability to increase our market share, our limited operating history, our ability to expand our business and significantly increase our revenues, our ability to effectively leverage our brand partnerships and sponsorships, our ability to effectively compete in our market, our ability to achieve our net sales guidance, and our ability to report profitable operations in the future. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading “Risk Factors” in cbdMD, Inc.’s Annual Report on Form 10-K for the fiscal year ended September 30, 2019 as filed with the Securities and Exchange Commission (the “SEC”) and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.

1 Non-THC is defined as below the level of detection using validated scientific analytical tools

Contact:

PR:

cbdMD, Inc.

Lauren Greene

Communications Specialist

Lauren.Greene@cbdMD.com

(843) 743-9999

Investors:

cbdMD, Inc.

John Weston

Director of Investor Relations

John.Weston@cbdMD.com

(704) 249-9515

###

Share article on social media or email:



Office Practicum Announces Integration of Anytime Pediatrics Telehealth Capabilities within EHR


News Image

Ninety percent of independent pediatric practices are planning for ongoing telehealth use post-pandemic.

Office Practicum provides electronic health record (EHR) and billing solutions, while Anytime Pediatrics is a telehealth platform. Both companies focus completely on pediatrics and are dedicated to improving clinical and financial outcomes for this community.

The COVID-19 pandemic has caused a substantial increase in pediatric telehealth appointments across the country. But telemedicine is not meant only for times of crisis. It’s now an integral part of pediatric practices’ care offerings. Ninety percent of independent pediatric practices are planning for ongoing telehealth use post-pandemic.

Pediatric patients and their parents will continue to expect care delivered through telehealth for multiple reasons, including safety, convenience, and value. With this new union, the two companies have further solidified their commitment to the practices they serve by providing integration of OP’s EHR with Anytime Pediatrics’ telehealth solution.

“If practices don’t find a way to continue delivering this technology, families will find another venue to access these services,” said OP Medical Director Susan Kressly, M.D. “Innovative practices that look for ways to meet their families where they are will position themselves for continued success. Success will depend on sustainable workflows that include a clear vision of telehealth practice offerings. In addition, a solution that integrates the telehealth platform with the EHR is important for streamlined care delivery.”

Thanks to the single sign-on feature, pediatricians and their staff members will be able to easily and directly access the Anytime Pediatrics telehealth functionality from within OP’s EHR. Another time-saving component of the integration is streamlined appointment scheduling, meaning the demographic and scheduled appointment information is sent automatically from OP to Anytime Pediatrics. This eliminates the need to schedule visits in both platforms and results in sustainable workflows that increase productivity and clinical outcomes.

“As a fairly new pediatric company, we are ecstatic to not only partner with OP, but also integrate our product with their solution,” said Mick Connors, M.D., CEO of Anytime Pediatrics. “Our two companies are so aligned philosophically that aligning our technology made a great deal of sense. Our combined solution will be an amazing differentiator for pediatricians seeking to stay connected with their patients in every way and to do so seamlessly.”

Anytime Pediatrics is HIPAA-compliant, which is critically important for care delivery beyond the public health emergency. Some of the platform’s highlights include a virtual waiting room where staff can interact with patients in the same way they might in their offices and the ability for parents to securely upload photos, which can aid in visual diagnosis.

In addition, Anytime Pediatrics allows practices to customize their telemedicine workflows based on unique needs. Most practices start with pre-scheduled visits and consultations during normal business hours and later expand virtual care offerings for after-hours and walk-in appointments.

Both companies are excited about this new partnership because they know it will allow pediatric practices across the country to provide the care their patients need — now and well into the future.

Share article on social media or email:

Vantagepoint A.I. Software Doubles Down on Giving To Philanthropic Partners


Vantagepoint A.I. pays it forward to Shriners and The Children's Cancer Center in celebration of meeting the team's 2020 Sales Goal four months early.

The Vantagepoint A.I. team met its annual sales goal four months early; to celebrate, a significant donation was made to Shriners Hospitals for Children in the name of Bentley, patient ambassador.

“We’re happy to invest in the success of our charitable partners and the vital work that they do in our community…We feel it is incumbent upon us…to step up especially since many others just can’t right now.” Lane Mendelsohn, President Vantagepoint A.I.

At a time when many are pulling back from their corporate philanthropy, Vantagepoint A.I. continues giving and has even expanded donations across its philanthropic partnerships.

“We’re so happy to invest in the success of our charitable partners and the vital work that they do in our community,” said Lane Mendelsohn, President of Vantagepoint, “Our company has experienced growth and success over the last year that has allowed us to stay steadfast in our giving to Shriners and add our support to The Children’s Cancer Center. We feel it is incumbent upon us, in this remarkable time in our company history, to step up especially since many others just can’t right now.”

Vantagepoint goes beyond writing a donation check; their philanthropic partners become part of the Vantagepoint family – they are invited to join into Vantagepoint events. For example, the company recently celebrated meeting its annual sales goal four months ahead of schedule. Bentley Rogers, a Shriners patient-ambassador, and his family were included in the unique festivities when the team celebrated meeting their goal.

“What was especially meaningful for us is that we found out Bentley will be featured in a national commercial for Shriners, so we are pleased to announce we are donating $10,000 in Bentley’s name,” said Mendelsohn, “and we donated equally to our friends at The Children’s Cancer Center.”

See Bentley’s reaction to the news and the team’s remote celebration: https://youtu.be/ijffao5cvQ0 .

About Vantagepoint AI, LLC. Headquartered in Wesley Chapel, Fla., Vantagepoint AI, was the first company in the world to give independent traders the power of artificial intelligence for their home computers. VantagePoint software forecasts Stocks, Futures, Forex, and ETFs with proven accuracy of up to 87.4, predicting changes in market trend directions up to three days in advance to help traders find optimal times to make their trades. Consistently recognized as one of the Top 10 Places to Work in Tampa Bay, Vantagepoint AI and its President, Lane Mendelsohn, have also both been featured by Fortune Magazine and others. Family-owned, Vantagepoint employs over 65 team members and is actively committed to giving back in the Tampa Bay community. To see artificial intelligence in action, attend a free training or schedule a demonstration at http://www.vantagepointsoftware.com/demo

Media Contact: Lisa Moretti

Email: lisam@vantagepointsoftware.com

Share article on social media or email: